Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» heterozygous familial hypercholesterolemia
heterozygous familial hypercholesterolemia
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
clinical trials
Sarepta Therapeutics
DMD
Elevidys
Bridge Bio
ATTR-CM
acoramidis
Sanofi
Merck KGaA
MS
tolebrutinib
Pfizer
obesity
danuglipron
Novo Nordisk
Ozempic
Verve Therapeutics
heterozygous familial hypercholesterolemia
Roche
lung cancer
tiragolumab
Vertex Pharmaceutical
VS-548
pain
JNJ
Bristol Myers Squibb
FDA Outlines Path Forward for Verve’s Lead Candidate, VERVE-101
BioSpace
Mon, 12/5/22 - 10:55 pm
Verve Therapeutics
VERVE-101
FDA
heterozygous familial hypercholesterolemia
FDA Pauses Verve’s Trial Plan for Gene-Editing Therapy for High Cholesterol
MedCity News
Mon, 11/7/22 - 05:17 pm
Verve Therapeutics
gene editing
FDA
heterozygous familial hypercholesterolemia
VERVE-101
HeFH
